Clarification of Orphan-Drug Exclusivity Following Catalyst Pharms., Inc. v. Becerra

TitleClarification of Orphan-Drug Exclusivity Following Catalyst Pharms., Inc. v. Becerra
ToC Doc Clarification of Orphan-Drug Exclusivity Following Catalyst Pharms., Inc. v. Becerra
Docket Number2023-01179
Type Rule
Subject Clarification of Orphan-Drug Exclusivity Following Catalyst Pharms., Inc. v. Becerra

Publication Date2023-01-24
Last Updated Date 2023-01-23 08:15:11 -0500
Last Public Inspection2023-01-23
Filed At2023-01-23T08:45:00.000-05:00
PDF 2023-01179_PI.pdf (71229 bytes)
Download TXT / HTML / JSON
Number of Pages 4
Filing Typeregular
AgenciesFood and Drug Administration

You can find the raw source document below...

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied. OFR.report is not affiliated with the Office of the Federal Register or the US government in any way.

© OFR.report 2021